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Abstract
Aim: We evaluated the protective effects of dexpanthenol (Dxp) in rats with gentamicin (Genta)-induced nephrotoxicity by assessing 
a panel of biochemical and histopathologic parameters.
Material Methods: Forty rats were divided randomly into the following four groups: Control group, physiological saline solution (0.5 
cc intraperitoneally (i.p.) for 8 days; Dxp group, Dxp (500 mg/kg i.p.) for 8 days; Genta group, Genta (100 mg/kg, i.p.) for 8 days; and 
Genta+Dxp group, Gent a and Dxp (100 and 500 mg/kg i.p., respectively) for 8 days.
Results: TIn the Genta group, the urea, creatinine, tumor necrosis factor-alpha (TNF-α), total oxidant status (TOS), oxidative stress 
index (OSI) and malondialdehyde (MDA) levels were significantly higher and the catalase (CAT) and glutathione peroxidase (GSH-Px) 
activities were significantly lower than those in the control group. In the Genta+Dxp group, the urea, creatinine, and TNF-α, TOS, OSI 
and MDA levels were significantly lower and the CAT and GSH-Px activities were significantly higher than those in the Genta group. 
Histopathological investigation showed severe tubular necrosis in the Genta group, which was of lesser severity in the Genta+Dxp 
group. 
Conclusion: The biochemical and histopathologic results of this study indicate that Dxp can ameliorate Genta-induced nephrotoxicity.
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INTRODUCTION
Gentamicin (Genta) is an aminoglycoside antibiotic 
frequently used against infections caused by Gram 
negative bacteria. However, clinical use of Genta is limited 
by its nephrotoxicity and ototoxicity (1). High doses of 
Genta cause nephrotoxicity due to its accumulation in 
epithelial cells of the proximal renal tubules (2). Genta 
in rats leads to histopathological alterations such 
as edema, basal membrane interruption, apoptosis, 
and tubular necrosis (3).The mechanism of Genta-
induced nephrotoxicity is unclear but involves a number 
of factors including reactive oxygen species (ROS), 
inflammation, and apoptosis (4,5). Increased production 
of ROS, depressed antioxidant defenses, and excessive 
levels of proinflammatory cytokines play a key role 
in the pathogenesis of Genta-induced nephrotoxicity 
(6,7).Thus, various antioxidants and anti-inflammatory 
agents have been used to treat or prevent Genta-induced 
nephrotoxicity (8,9).
Dexpanthenol (Dxp), an alcohol derivative of pantothenic 
acid (PA), is oxidized to PA in tissues; this increases 
glutathione, coenzyme-A, and ATP synthesis (10). 
Dxp plays an important role in both cellular defense 
against oxidative stress and the inflammatory response 
(11,12). Hence, we investigated the antioxidant and anti-
inflammatory effects of Dxp in rats with Genta-induced 




Genta sulfate (Genta ampoule 80 mg, I.E. Istanbul, Turkey) 
and Dxp (Bepanthene ampoule 500 mg/2 mL, Bayer) were 
used in this study. 
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Animals
Forty male Wistar albino rats weighing 250–300 g 
were used in this study. The Mustafa Kemal University 
Experimental Animals Local Ethics Committee approved 
the study (Approval No., 2015/5-4). The experiment was 
carried out in Mustafa Kemal University Experimental 
Researches Application and Research Center, Hatay, 
Turkey. The rats were fed ad libitum and housed in 
appropriate cages, each containing five rats. The rats 
were exposed to a 12/12 h light/dark cycle at 20–22°C 
and 50–55% humidity.
Experimental Design
Forty rats were divided into four groups. Physiological 
saline was injected (0.5 mL intraperitoneally (i.p.) for 
8 days to the rats in the control group. Dxp (500 mg/kg 
i.p.) was injected for 8 days to the rats in the Dxp group 
(13,14).The rats in the Genta group received injections 
of Genta (100 mg/kg i.p.) for 8 days (15).The rats in the 
Genta+Dxp group were injected with Genta and Dxp (100 
and 500 mg/kg i.p., respectively) for 8 days.
Twenty-four hours after the last injection, the rats were 
anesthetized with ketamine hydrochloride (60 mg/kg i.p.) 
and xylazine hydrochloride (10 mg/kg i.p.), subjected 
to intracardiac blood sampling, and decapitated. A 
midline abdominal incision was made, and the left 
kidney was removed and transferred to the laboratory in 
10% neutral formaldehyde solution in a closed labeled 
bottle for histopathological evaluation. The right kidney 
was removed, covered with labeled aluminum foil, 
and transferred in liquid nitrogen to the biochemistry 
laboratory. Blood samples were centrifuged at 1,500 rpm 
for 10 minutes and serum samples were stored at −80°C 
until required. The biochemical parameters assessed 
were the serum urea, creatinine, total antioxidant status 
(TAS), total oxidant status (TOS), and tumor necrosis 
factor-alpha (TNF-α) levels. The malondialdehyde (MDA) 
level, catalase (CAT) activity, and glutathione peroxidase 
(GSH Px) activity in renal tissue were also evaluated.
Biochemical Analysis
The TOS and TAS levels were determined by the method of 
Erel (16,17).The oxidative stress index (OSI) was defined as 
the TOS to TAS ratio.The serum levels of urea, creatinine, 
Na, and K were measured spectrophotometrically using 
an Architect c8000 analyzer (Abbott Diagnostics).The 
serum TNF-α level was measured using an enzyme-linked 
immunosorbent assay kit (Awareness Technology Inc. 
ChroMate ELISA) and expressed as pg/mL protein. CAT 
activity was evaluated by the method of Aebi (18). GSH-Px 
activity was measured according to the recommendations 
of Paglia and Valentine (19). The MDA level was evaluated 
by the method of Draper and Hadley (20).
Histopathological Analysis
Renal tissue samples were fixed in 10% neutral 
formaldehyde solution and embedded in paraffin. Paraffin 
sections (4 μm thickness) were cut using a microtome and 
stained with hematoxylin and eosin. The sections were 
visualized using a light microscope. Tubular necrosis, 
tubular degeneration, congestion, tubular hypertrophy, 
and perivascular inflammation were evaluated by light 
microscopy. A predetermined scoring system was used 
for histopathologic evaluation (21). Tissue damage was 
scored as follows: +, slight; ++, moderate; and +++, severe.
Statistical analysis
Statistical analyses were performed using SPSS ver. 21 
(SPSS Inc., Chicago, IL, USA). The values are expressed 
as mean ± SEM. The groups were compared by one-way 
analysis of variance (ANOVA) followed by Tukey’s test. A 




The results of the oxidative stress and biochemical 
parameters in rats with Genta-induced nephrotoxicity are 
shown in Table 1 and 2. The urea, creatinine and TNF-α 
levels were significantly higher in the Genta group than 
in the control group and were significantly lower in the 
Genta+Dxp group than in the Genta group (p < 0.05). 
The serum Na level did not differ significantly among the 
groups, but the serum K level was significantly lower in 
the Genta+Dxp group than in the Dxp group (p < 0.05) 
(Table 1). 
Table 1. Effects of dexpanthenol (Dxp) on biochemical parameters
Parameters  Control  Dxp Genta Genta+Dxp
TNF-α (pg/mL protein) 115.5± 8.1 335.8±84.8 899.3±181.3* 386.3 ±65.4**
Urea (mg/dL) 20.3±0.25  20.7±0.37 130.8±29.8* 61.9 ± 11.9**
Creatinine (mg/dL) 0.5±0.01 0.49±0.0  2.55±0.6* 1.04 ± 0.24**
Na (mmol/L) 135.5±1.4 138.2±0.4 134.7±1.57 139.1 ± 0.89
K (mmol/L)  5.67±0.3 5.72±0.17 5.32±0.27 4.6 ± 0.21***
Data were expressed as Mean ± SEM. TNF-α: Tumor necrosis factor-alpha, Na: Sodium, K: Potassium.
*p<0.05 vs. Control group
**p<0.05 vs. Genta group 
***p<0.05 vs. Dexa group
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The TOS, OSI and MDA levels  were higher in the Genta 
group than in the control group and were significantly 
lower in the Genta+Dxp group than in the Genta group (p < 
0.05). However, the TAS did not differ significantly among 
the four groups (p > 0.05). The CAT and GSH-Px levels 
were lower in the Genta group than in the control group 
and were significantly higher in the Genta+Dxp group than 
in the Genta group (p < 0.05) (Table 2). 
Histological results
The renal tissues were histopathologically evaluated 
for tubular necrosis, tubular degeneration, glomerular 
atrophy and hypertrophy, and perivascular inflammation. 
The control and Dxp groups had normal renal tissue 
(Figure 1A and 1B). The rats in the Genta group had 
marked proximal tubular necrosis, tubular degeneration, 
perivascular inflammation (interstitial nephritis and 
pyelonephritis), and marked glomerular hypertrophy 
(Figure 1C). The rats in the Genta+Dxp group showed mild 
tubular necrosis, glomerular atrophy, and perivascular 
inflammation and moderate tubular degeneration and 
glomerular hypertrophy (Figure 1D).
Table 1. Effects of dexpanthenol (Dxp) on biochemical parameters
Parameters  Control  Dxp Genta Genta+Dxp
TAS (µmol Trolox Eq/g protein) 0.92 ± 0.07 0.94 ± 0.03 0.86 ± 0.07 0.98 ± 0.03
TOS (µmol H2O2 Eq/ g protein) 12.6 ± 1.00 16.9 ± 2.00 31.5 ± 4.84* 19.4 ± 2.28**
OSI (H2O2/Trolox) 1.39 ± 0.14 1.92 ± 0.24 3.65 ± 0.49* 1.98 ± 0.22**
MDA 0.46 ± 0.02 0.45 ± 0.02 1.05 ± 0.04* 0.71 ± 0.03**
CAT 0.07 ± 0.00 0.07 ± 0.02 0.03 ± 0.00* 0.04 ± 0.00** 
GSH- Px 0.32 ± 0.01 0.30 ± 0.01 0.18 ± 0.00* 0.23 ± 0.01** 
Data were expressed as Mean ± SEM. TAS: Total antioxidant status, TOS: Total oxidant status, OSI: Oxidative stress index, MDA: Malondialdehyde, 
CAT: Catalase, GSH Px: glutathione peroxidase.
*p<0.05 vs. Control group
**p<0.05 vs. Genta group 
DISCUSSION
We evaluated the protective effect of Dxp on Genta induced 
nephrotoxicity. The results showed that Dxp ameliorated 
the renal injury caused by high-dose Genta by decreasing 
oxidative stress and the inflammation.  
Clinical use of aminoglycosides is restricted by their 
nephrotoxicity, which is caused by generation of ROS (5). 
In renal pathology, NADPH oxidases, together with the 
mitochondrial respiratory chain, are the major sources 
of ROS such as the superoxide anion (O2•-), hydrogen 
peroxide (H2O2), and the hydroxyl radical (•OH) (22). 
Abnormal production of ROS leads to cellular injury and 
necrosis by inducing membrane lipid peroxidation, protein 
denaturation, and damage to DNA. The changes in renal 
function caused by lipid peroxidation are considered to be 
the initial event in the Genta-induced nephrotoxicity injury 
cascade (5,23). Genta increases ROS production, reduces 
the antioxidant capacity, and increases lipid peroxidation 
(24,25). Genta-induced renal injury can be prevented by 
various agents (6,9). In this study, we investigated for 
the first time the therapeutic effects of Dxp, which has 
antioxidant and anti-inflammatory activity, on Genta-
induced nephrotoxicity.
Genta causes nephrotoxicity by decreasing the glomerular 
filtration rate and increasing the serum urea and creatinine 
levels (26,27). In our study, Genta led to a significant 
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increase in the serum urea and creatinine levels, whereas 
Genta+Dxp induced a significant decrease in the serum 
urea and creatinine levels. These results suggest a role for 
Dxp in preventing Genta-induced nephrotoxicity.
Inflammatory reactions, which are characterized by 
leukocyte infiltration into the injury site, increase the 
production of proinflammatory cytokines, such as TNF-α, 
and activation of nuclear factor-κB, also play an important 
role in the nephrotoxicity of Genta (5,28). In our study, the 
TNF-α level was significantly higher in the Genta group 
and significantly lower in the Genta+Dxp group compared 
to the Genta group. Thus, the anti inflammatory activity of 
Dxp suppressed renal inflammation.
Excess ROS production caused by the nephrotoxic effect 
of Genta damages cells by interacting with membrane 
lipids. MDA is a product of lipid peroxidation by ROS (22). 
In our study, as in prior reports, Genta led to a significant 
increase in the MDA level (29,30). In contrast, the MDA 
level was significantly lower in the Genta+Dxp group 
compared to the Genta group.
GSH-Px and CAT are enzymatic antioxidants that protect 
cells against the negative effects of free radicals, for 
example, by converting H2O2 into H2O (31). In this study, 
the GSH-Px and CAT activities were lower in the Genta 
group than in the control group, as reported previously 
(23,26). On the other hand, GSH-Px and CAT activities 
were higher in the Genta+Dxp group than in the Genta 
group.
We also measured the TAS, TOS, and OSI to evaluate 
the oxidant and antioxidant status in Genta-induced 
nephrotoxicity. The TOS and the OSI value were 
significantly higher in the Genta group compared 
to the control group; this increase was reversed by 
simultaneous administration of Dxp with Genta. These 
results indicate that Dxp reduces the level of oxidative 
stress induced by Genta. Collectively, our results showed 
that Dxp administration increases the activities of GSH-
Px and CAT and decreases the TOS and the OSI value and 
the level of MDA. This effect is likely to be mediated by 
the antioxidant activity of Dxp, which protects the kidney 
against free oxygen radicals. Similarly, Dxp protected 
against ischemia-reperfusion-induced renal injury in rats 
(32,33). Thus, Dxp has antioxidant activity and reduces 
the generation of free radicals.
Genta-induced nephrotoxicity is morphologically 
characterized by proximal tubule epithelial desquamation, 
epithelial edema, glomerular congestion, necrosis, and 
tubular casts (34). In this study, the renal tissue of the 
rats in the Genta group exhibited marked glomerular 
hypertrophy, perivascular inflammation, congestion, 
tubular degeneration, and tubular necrosis. Thus, Genta 
induced severe renal injury. In the Genta+Dxp group, 
however, Genta induced moderate renal injury, suggesting 
that Dxp ameliorated the tubular injury caused by Genta. 
Also, the histopathological changes were consistent with 
the biochemical findings. 
CONCLUSION
Our results showed that Genta-induced nephrotoxicity 
in rats was ameliorated by the anti-inflammatory and 
antioxidant effects of Dxp. We believe that Dxp can be used 
safely in clinical practice to prevent Genta-induced kidney 
damage. However, further studies of the protective effect 
of Dxp on Genta-induced nephrotoxicity are required.
Acknowledgments
This work was presented at the 28th National and 1. International 
Biochemistry Congress, Erzurum, 2017.
Competing interests: The authors declare that they have no competing 
interest. 
Financial Disclosure: This research was supported by a grant from 
Mustafa Kemal University Research Fund (14300/2015).
Ethical approval: The Mustafa Kemal University Experimental Animals 






1. Quiros Y, Vicente-Vicente L, Morales AI, et al. An integrative 
overview on the mechanisms underlying the renal tubular 
cytotoxicity of gentamicin. Toxicol Sci 2011;119: 245–56. 
2. Nagai J, Takano M. Molecular aspects of renal handling 
of aminoglycosides and strategies for preventing the 
nephrotoxicity. Drug Metab Pharmacokinet 2004;19:159-
70.
3. De Souza VB, Oliveira RFL, Lucena HF, et al. Gentamicin 
induces renal morphopathology in wistar rats. Int J Morphol 
2009;27:59-63.
4. Lee KE, Kim EY, Kim CS, et al. Macrophage-stimulating 
protein attenuates gentamicin-induced inflammation and 
apoptosis in human renal proximal tubular epithelial cells. 
Biochem Biophys Res Commun 2013;434:527–33.
5. Balakumar P, Rohilla A, Thangathirupathi A. Gentamicin 
induced nephrotoxicity: Do we have a promising therapeutic 
approach to blunt it? Pharmacol Res 2010;62:179-86.
6. Fouad AA, Albuali WH, Zahran A, et al. Protective effect of 
naringenin against gentamicin-induced nephrotoxicity in 
rats. Environ Toxicol Pharmacol 2014;38:420-9. 
7. El-Kashef DH, El-Kenawi AE, Suddek GM, et al. Protective 
effect of allicin against gentamicin-induced nephrotoxicity 
in rats. Int Immunopharmacol 2015;29:679-86. 
8. Abuelezz SA, Hendawy N, Abdel Gawad S. Alleviation of 
renal mitochondrial dysfunction and apoptosis underlies 
the protective effect of sitagliptinin gentamicin-induced 
nephrotoxicity. J Pharm Pharmacol 2016;68:523-32. 
9. Aygün FO, Akçam FZ, Kaya O, et al. Caffeic acid phenethyl ester 
modulates gentamicin-induced oxidative nephrotoxicity in 
kidney of rats. Biol Trace Elem Res 2012;145:211–6.
10. Slyshenkov VS, Dymkowska D, Wojtczak L. Pantothenic 
acid and pantothenol increase biosynthesis of glutathione 
by boosting cell energetics. FEBS Lett 2004;569:169-72. 
11. Doğan EE, Erkoç R, Ekinci İ, et al. Protective effect of 
dexpanthenol against nephrotoxic effect of amikacin: An 
experimental study. Biomed Pharmacother 2017;89:1409-
14. 
12. Li-Mei W, Jie T, Shan-He W, et al.  Anti-inflammatory and anti-
oxidative effects of dexpanthenol on lipopolysaccharide 
Ann Med Res 2019;26(9):1787-91
1791
induced acute lung injury in mice. Inflammation 
2016;39:1757-63. 
13. Ermiş H, Parlakpinar H, Gulbaş G, et al. Protective effect 
of dexpanthenol on bleomycin-induced pulmonary 
fibrosis in rats. Naunyn Schmiedebergs Arch Pharmacol 
2013;386:1103-10.
14. Cagin YF, Parlakpinar H, Vardi N, et al. Effects of 
dexpanthenol on acetic acid-induced colitis in rats. Exp 
Ther Med 2016;12:2958-64.
15. Polat A, Parlakpinar H, Tasdemir S, et al. Protective role of 
aminoguanidine on gentamicin-induced acute renal failure 
in rats. Acta Histochem 2006;108:365-71. 
16. Erel O. A novel automated method to measure total 
antioxidant response against potent free radical reactions. 
Clin Biochem 2004;37:112-9.
17. Erel O. A new automated colorimetric method for measuring 
total oxidant status. Clin Biochem 2005;38:1103-11.
18. Aebi H. Catalase in vitro. Methods Enzymol 1984;105:121–
6.
19. Paglia DE, Valentine WN. Studies on the quantitative and 
qualitative characterization of erythrocyte glutathione 
peroxidase. J Lab Clin Med 1967;70:158-69.
20. Draper HH, Hadley M. Malondialdehyde determination 
as index of lipid-peroxidation. Methods Enzymol 
1990;186:421-31.
21. Ouédraogo M, Lamien-Sanou A, Ramdé N, et al. Protective 
effect of Moringa oleifera leaves against gentamicin-
induced nephrotoxicityin rabbits. ExpToxicol Pathol 
2013;65:335-9. 
22. Ratliff  BB, Abdulmahdi W, Pawar R, et al. Oxidant 
mechanisms in renal injury and disease. Antioxid Redox 
Signal 2016;25:119-46.
23. Parlakpinar H, Tasdemir S, Polat A, et al. Protective role of 
caffeic acid phenethyl ester (cape) on gentamicin-induced 
acute renal toxicity in rats. Toxicology 2005;207:169-77.
24. Kandemir FM, Ozkaraca M, Yildirim BA, et al. Rutin 
attenuates gentamicin-induced renal damage by reducing 
oxidative stress, inflammation, apoptosis, and autophagy in 
rats. Ren Fail 2015;37:518-25.
25. Abdelsameea AA, Mohamed AM, Amer MG, et al. Cilostazol 
attenuates gentamicin-induced nephrotoxicity in rats. Exp 
Toxicol Pathol 2016;68:247-53. 
26. Abdel-Raheem IT, Abdel-Ghany AA, Mohamed GA. 
Protective effect of quercetin against gentamicin-induced 
nephrotoxicity in rats. Biol Pharm Bull 2009;32:61-7.
27. Sardana A, Kalra S, Khanna D, et al. Nephroprotective 
effect of catechin on gentamicin-induced experimental 
nephrotoxicity. Clin Exp Nephrol 2015;19:178-84.
28. Bae EH, Kim IJ, Joo SY, et al. Renoprotective effects of 
the direct renin inhibitor aliskiren on gentamicin-induced 
nephrotoxicity in rats. J Renin Angiotensin Aldosterone Syst 
2014;15:348-61.
29. El-Kashef DH, El-Kenawi AE, Suddek GM, et al. Flavocoxid 
attenuates gentamicin induced nephrotoxicity in rats. 
Naunyn Schmiedebergs Arch Pharmacol 2015;388:1305-
15. 
30. Boroushaki MT, Asadpour E, Sadeghnia HR, et al. Effect 
of pomegranate seed oil against gentamicin-induced 
nephrotoxicity in rat. J Food Sci Technol 2014;51:3510-4. 
31. Özcan O, Erdal H, Çakırca G, et al. Oxidative stress and its 
impacts on intracellular lipids, proteins and DNA. J Clin Exp 
Invest 2015;6:331-6.
32. Altintas R, Parlakpinar H, Beytur A, et al. Protective effect of 
dexpanthenol on ischemia-reperfusion-induced renal injury 
in rats. Kidney Blood Press Res 2012;36:220-30.
33. Sen H, Deniz S, Yedekci AE, et al. Effects of dexpanthenol 
and N-acetylcysteine pretreatment in rats before renal 
ischemia/reperfusion injury. Ren Fail 2014;36:1570-4. 
34. Lakshmi BVS, Sudhakar M. Protective effect of Zingiber 
officinale on gentamicin induced nephrotoxicity in rats. Int 
J Pharmacol 2010;6:58-62.
